| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Eric T Wong | |
| Anna Berkenblit | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 68-79 | |
| P577 | publication date | 2004-01-01 | |
| P1433 | published in | Oncologist | Q2122327 |
| P1476 | title | The role of topotecan in the treatment of brain metastases | |
| P478 | volume | 9 |
| Q37081122 | A phase III trial of topotecan and whole brain radiation therapy for patients with CNS-metastases due to lung cancer |
| Q39793510 | Antimetastatic activity of MONCPT in preclinical melanoma mice model |
| Q92489979 | Assessing the Effectiveness of Systemic Therapy after Stereotactic Radiosurgery on Cancer Recurrence and All-Cause Mortality |
| Q37591290 | Blood-brain barrier transporters and response to CNS-active drugs |
| Q35614139 | Brain metastasis from uterine serous carcinoma: A case report and review of literature |
| Q48476085 | Brain metastasis in patients with uterine cervical cancer. |
| Q38222247 | Brain metastasis: new opportunities to tackle therapeutic resistance |
| Q34491446 | CK2-mediated hyperphosphorylation of topoisomerase I targets serine 506, enhances topoisomerase I-DNA binding, and increases cellular camptothecin sensitivity |
| Q36577335 | Cerebral metastases--a therapeutic update |
| Q38223435 | Chemotherapeutic drugs that penetrate the blood-brain barrier affect the development of hyperactive delirium in cancer patients |
| Q36641504 | Chemotherapy and targeted molecular therapies for brain metastases |
| Q28508220 | DNA topoisomerase I in the mouse central nervous system: Age and sex dependence |
| Q33386298 | Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study. |
| Q36562978 | Examination of blood-brain barrier (BBB) integrity in a mouse brain tumor model |
| Q46265949 | Glutamate regulates the activity of topoisomerase I in mouse cerebellum |
| Q36590195 | Innovative therapeutic strategies in the treatment of brain metastases |
| Q36631335 | Intrathecal topotecan in adult patients with neoplastic meningitis |
| Q37001278 | Overlapping functions of ABC transporters in topotecan disposition as determined in gene knockout mouse models. |
| Q37368787 | Phase II clinical trial of whole-brain irradiation plus three-dimensional conformal boost with concurrent topotecan for brain metastases from lung cancer |
| Q35967411 | Preclinical approaches to study the biology and treatment of brain metastases |
| Q27318630 | R-loops in proliferating cells but not in the brain: implications for AOA2 and other autosomal recessive ataxias |
| Q92178050 | Rare Distant Metastatic Disease of Ovarian and Peritoneal Carcinomatosis: A Review of the Literature |
| Q48727631 | Reirradiation of multiple brain metastases with helical tomotherapy. A multifocal simultaneous integrated boost for eight or more lesions |
| Q35101351 | Roles for endothelin receptor B and BCL2A1 in spontaneous CNS metastasis of melanoma |
| Q46979299 | Small cell lung cancer--state of the art and future perspectives |
| Q36038367 | Systemic Chemotherapy for Progression of Brain Metastases in Extensive-Stage Small Cell Lung Cancer |
| Q81607522 | Systemic high-dose intravenous methotrexate for central nervous system metastases |
| Q37586262 | The role of chemotherapy in the treatment of patients with brain metastases from solid tumors |
| Q58023833 | Therapie von Hirnmetastasen und Meningeosis neoplastica |
| Q85185650 | Topotecan and ifosfamide systemic chemotherapy for CNS involvement of solid tumors |
| Q33376813 | Topotecan as salvage therapy for relapsed or refractory primary central nervous system lymphoma |
| Q36106920 | Treating brain metastases: current approaches and future directions |
| Q35313640 | Tumor bed radiosurgery following resection and prior stereotactic radiosurgery for locally persistent brain metastasis |
Search more.